94660-8SARS-CoV-2 (COVID-19) RNA [Presence] in Serum or Plasma by NAA with probe detectionActive
Term Description
Qualitative detection of SARS coronavirus 2 (SARS-CoV-2) in serum or plasma specimens by nucleic acid amplification with probe-based detection. Results may be based on multiple assays to determine the presence of the virus in a specimen.
Source: Regenstrief LOINC
Part Description
LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility.[PMID:31953166] Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.
The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus.
Source: LOINC
Fully-Specified Name
- Component
- SARS coronavirus 2 RNA
- Property
- PrThr
- Time
- Pt
- System
- Ser/Plas
- Scale
- Ord
- Method
- Probe.amp.tar
Additional Names
- Short Name
- SARS-CoV-2 RNA SerPl Ql NAA+probe
- Display Name
- SARS-CoV-2 (COVID-19) RNA NAA+probe Ql
- Consumer Name Alpha
- SARS-CoV-2 (COVID-19), Blood
Ask At Order Entry
This panel contains a convenience grouping of terms for questions commonly asked when an order is placed in a public health laboratory.
| LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
|---|---|---|---|---|
| 81959-9 | Public health laboratory ask at order entry panel | |||
| Indent81744-5 | Submitter's laboratory test method [Type] in Specimen | |||
| Indent81658-7 | Suspected organism [Identifier] in Specimen | |||
| Indent86952-9 | Preliminary testing done Specimen | |||
| Indent86953-7 | Preliminary testing result Specimen | |||
| Indent86955-2 | Preliminary testing affected submission for further testing Specimen | |||
| Indent95417-2 | Whether this is the patient's first test for condition of interest | |||
| Indent95418-0 | Whether patient is employed in a healthcare setting | |||
| Indent95419-8 | Whether the patient has symptoms related to condition of interest | |||
| Indent11368-8 | Illness or injury onset date and time | C | ||
| Indent77974-4 | Whether the patient was hospitalized for condition of interest | |||
| Indent95420-6 | Whether the patient was admitted to intensive care unit (ICU) for condition of interest | |||
| Indent95421-4 | Whether patient resides in a congregate care setting | |||
| Indent82810-3 | Pregnancy status | C | ||
| Indent30525-0 | Age | a |
Example Answer List LL744-4
Source: Regenstrief Institute
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Detected | LA11882-0 | ||
| Not detected | LA11883-8 |
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.68
- Last Updated
- Version 2.69
- Order vs. Observation
- Both
Reference Information
| Type | Source | Reference |
|---|---|---|
| Webcontent | Lab Tests Online®Copyright Copyright © 2021 Lab Tests Online. All rights reserved. | Coronavirus (COVID-19) Testing |
Member of these Groups
| LG51017-8 | SARSCoV2 detection |
| LG51019-4 | SARSCoV2 molecular detection |
Language Variants Get Info
- zh-CNChinese (China)
- SARS 冠状病毒 2 RNA:
存在情况或阈值: 时间点: 血清/血浆: 序数型: 探针法.基因扩增.靶向 - nl-NLDutch (Netherlands)
- SARS-CoV-2 RNA:
aanwezigheid: moment: serum of plasma: ordinaal: moleculaire techniek (PCR) - fr-CAFrench (Canada)
- coronavirus 2 du SRAS , ARN:
Présence-Seuil: Temps ponctuel: Sérum/Plasma: Ordinal: Sonde avec amplification de la cible - fr-FRFrench (France)
- Coronavirus SARS-CoV-2 ARN:
Présence/Seuil: Ponctuel: Sérum/Plasma: Qualitatif: PCR amplification de cible - de-DEGerman (Germany)
- SARS-Coronavirus 2 RNA:
Nachweis oder Schwellenwert: Zeitpunkt: Serum oder Plasma: Ordinal: Zielfragmentamplifikation mit Sondendetektion - it-ITItalian (Italy)
- SARS coronavirus 2 RNA:
PrThr: Pt: Siero/Plasma: Ord: Sonda.amp.tar - es-MXSpanish (Mexico)
- ARN del coronavirus 2 del SARS:
Presencia o umbral: Punto temporal: Suero o Plasma: Ordinal: Amplificación de ácidos nucleicos con detección de sonda - es-ESSpanish (Spain)
- Panel del SARS-CoV-2 (COVID-19) RNA:
PrThr: Punto temporal: Suero o Plasma: Ord: Sonda con amplificación dirigida
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=94660-8
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright